This study evaluated the benefits of a more versus a less intensive blood pressure (BP) lowering treatment strategy in patients with hypertension (high blood pressure). The data showed that a more intensive BP lowering treatment strategy significantly reduced the risks of stroke, heart failure, heart attacks, and cardiovascular death compared to a less intensive BP-lowering treatment strategy in these patients.

This study evaluated the effectiveness of trimetazidine (Vastarel) versus other anti-anginal drugs for the treatment of patients with ischemic heart disease (IHD) who are not suitable for revascularization. The data showed that trimetazidine improved walking time and angina attacks in these patients.

This study determined the effect of varying carbohydrate and saturated fat dietary contents on cardiovascular disease (CVD) risk factors during weight-loss maintenance. The authors concluded that restriction of carbohydrates provided improved insulin resistance on lipoprotein metabolism, without unwanted side effects on low-density lipoprotein (LDL) cholesterol or inflammation.

This study examined whether the appearance of the corneal nerve located in the eye can predict the development of diabetic peripheral neuropathy.

This study compared the effectiveness and safety of two drugs in the treatment of type 2 diabetes patients with kidney disease.

This study examined whether the appearance of blood vessels in the eye can predict long-term vascular complications in type 1 diabetics.

This study examined whether a dietary supplement containing cinnamon, chromium and carnosine could reduce fasting blood glucose (sugar) levels in pre-diabetics.

This study examined whether Ly 2963016 insulin glargine is safe and effective in type 2 diabetics.

This study examined whether type 1 diabetic men with cardiovascular autonomic neuropathy are more likely to have urogenital complications.

This study examined the use of glutamine and sitagliptin as a treatment for type 2 diabetes mellitus.